The dual role of lipids in chronic kidney disease: Pathogenic culprits and therapeutic allies

被引:3
作者
Giardini, Elena [1 ,2 ]
Moore, Dean [1 ,2 ]
Sadlier, Denise [3 ]
Godson, Catherine [1 ,2 ]
Brennan, Eoin [1 ,2 ]
机构
[1] Univ Coll Dublin, Conway Inst, Diabet Complicat Res Ctr, Dublin, Ireland
[2] Univ Coll Dublin, Sch Med, Dublin, Ireland
[3] Mater Misericordiae Univ Hosp, Eccles St, Dublin, Ireland
基金
爱尔兰科学基金会;
关键词
Lipids; Pro-resolving mediators; Lipoxsin; Resolvins; Maresins; Protectins; inflammation; chronic kidney disease; Glomerulosclerosis; Tubulointerstitial fibrosis; ENDOPLASMIC-RETICULUM STRESS; LIPOXIN A(4); RESOLVIN D1; ANTIINFLAMMATORY ACTIONS; MACROPHAGE PHAGOCYTOSIS; APOPTOTIC NEUTROPHILS; DIABETIC-NEPHROPATHY; RECEPTOR; INFLAMMATION; RESOLUTION;
D O I
10.1016/j.atherosclerosis.2024.118615
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic kidney disease (CKD) is a significant health burden, with rising incidence and prevalence, attributed in part to increasing obesity and diabetes rates. Lipid accumulation in the kidney parenchyma and chronic, lowgrade inflammation are believed to significantly contribute to the development and progression of CKD. The effect of dysregulated kidney lipid metabolism in CKD progression, including altered cholesterol and fatty acid metabolism contribute to glomerular and tubular cell injury through the activation of oxidative stress and inflammatory signalling cascades. In contrast, classes of endogenous specialized pro-resolving lipid mediators (SPMs) have been described that act to limit the inflammatory response and promote the resolution of inflammation. This review highlights our current understanding of how lipids can cause damage within the kidney, and classes of protective lipid metabolites that offer therapeutic benefits.
引用
收藏
页数:10
相关论文
共 135 条
  • [1] Maresin 1 biosynthesis during platelet-neutrophil interactions is organ-protective
    Abdulnour, Raja-Elie E.
    Dalli, Jesmond
    Colby, Jennifer K.
    Krishnamoorthy, Nandini
    Timmons, Jack Y.
    Tan, Sook Hwa
    Colas, Romain A.
    Petasis, Nicos A.
    Serhan, Charles N.
    Levy, Bruce D.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (46) : 16526 - 16531
  • [2] Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis
    Arita, M
    Yoshida, M
    Hong, S
    Tjonahen, E
    Glickman, JN
    Petasis, NA
    Blumberg, RS
    Serhan, CN
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (21) : 7671 - 7676
  • [3] Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1
    Arita, M
    Bianchini, F
    Aliberti, J
    Sher, A
    Chiang, N
    Hong, S
    Yang, R
    Petasis, NA
    Serhan, CN
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (05) : 713 - 722
  • [4] Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation
    Arita, Makoto
    Ohira, Taisuke
    Sun, Yee-Ping
    Elangovan, Siva
    Chiang, Nan
    Serhan, Charles N.
    [J]. JOURNAL OF IMMUNOLOGY, 2007, 178 (06) : 3912 - 3917
  • [5] Resolvin D3 Is Dysregulated in Arthritis and Reduces Arthritic Inflammation
    Arnardottir, Hildur H.
    Dalli, Jesmond
    Norling, Lucy V.
    Colas, Romain A.
    Perretti, Mauro
    Serhan, Charles N.
    [J]. JOURNAL OF IMMUNOLOGY, 2016, 197 (06) : 2362 - 2368
  • [6] The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
    Baigent, Colin
    Landray, Martin J.
    Reith, Christina
    Emberson, Jonathan
    Wheeler, David C.
    Tomson, Charles
    Wanner, Christoph
    Krane, Vera
    Cass, Alan
    Craig, Jonathan
    Neal, Bruce
    Jiang, Lixin
    Hooi, Lai Seong
    Levin, Adeera
    Agodoa, Lawrence
    Gaziano, Mike
    Kasiske, Bertram
    Walker, Robert
    Massy, Ziad A.
    Feldt-Rasmussen, Bo
    Krairittichai, Udom
    Ophascharoensuk, Vuddidhej
    Fellstrom, Bengt
    Holdaas, Hallvard
    Tesar, Vladimir
    Wiecek, Andrzej
    Grobbee, Diederick
    de Zeeuw, Dick
    Gronhagen-Riska, Carola
    Dasgupta, Tanaji
    Lewis, David
    Herrington, William
    Mafham, Marion
    Majoni, William
    Wallendszus, Karl
    Grimm, Richard
    Pedersen, Terje
    Tobert, Jonathan
    Armitage, Jane
    Baxter, Alex
    Bray, Christopher
    Chen, Yiping
    Chen, Zhengming
    Hill, Michael
    Knott, Carol
    Parish, Sarah
    Simpson, David
    Sleight, Peter
    Young, Alan
    Collins, Rory
    [J]. LANCET, 2011, 377 (9784) : 2181 - 2192
  • [7] NSAIDs in CKD: Are They Safe?
    Baker, Megan
    Perazella, Mark A.
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 76 (04) : 546 - 557
  • [8] Lipoxin A4: Anti-Inflammatory and Anti-Angiogenic Impact on Endothelial Cells
    Baker, Nicole
    O'Meara, Sarah J.
    Scannell, Michael
    Maderna, Paola
    Godson, Catherine
    [J]. JOURNAL OF IMMUNOLOGY, 2009, 182 (06) : 3819 - 3826
  • [9] Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
    Bakris, George L.
    Agarwal, Rajiv
    Anker, Stefan D.
    Pitt, Bertram
    Ruilope, Luis M.
    Rossing, Peter
    Kolkhof, Peter
    Nowack, Christina
    Schloemer, Patrick
    Joseph, Amer
    Filippatos, Gerasimos
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (23) : 2219 - 2229
  • [10] Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy A Randomized Clinical Trial
    Bakris, George L.
    Agarwal, Rajiv
    Chan, Juliana C.
    Cooper, Mark E.
    Gansevoort, Ron T.
    Haller, Hermann
    Remuzzi, Giuseppe
    Rossing, Peter
    Schmieder, Roland E.
    Nowack, Christina
    Kolkhof, Peter
    Joseph, Amer
    Pieper, Alexander
    Kimmeskamp-Kirschbaum, Nina
    Ruilope, Luis M.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (09): : 884 - 894